Bridgebio Pharma, Inc. · NASDAQ:BBIO

Apuli Maricel sold 2,000 Bridgebio Pharma, Inc. shares (Form 4)

Traded Jul 30, 2026 · Filed Aug 3, 2026

On Jul 30, 2026, Apuli Maricel (Chief Accounting Officer) sold 2,000 Bridgebio Pharma, Inc. shares at US$80.06 for US$160K under a trading plan, leaving 127,401 shares. Filed Aug 3, 2026 (Form 4).

Sold
2,000 shares
Price
US$80.06
Value
US$160K
Holding after
127,401 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockSale2,000US$80.06127,401Direct

Source

View original at SEC

Related